Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Prostate cancer risk among men with diabetes mellitus (Spain).

González-Pérez A, García Rodríguez LA.

Cancer Causes Control. 2005 Nov;16(9):1055-8.

PMID:
16184470
2.

No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.

Kowall B, Stang A, Rathmann W, Kostev K.

Pharmacoepidemiol Drug Saf. 2015 Aug;24(8):865-74. doi: 10.1002/pds.3823. Epub 2015 Jul 1.

PMID:
26132313
3.

Metformin use and prostate cancer risk.

Preston MA, Riis AH, Ehrenstein V, Breau RH, Batista JL, Olumi AF, Mucci LA, Adami HO, Sørensen HT.

Eur Urol. 2014 Dec;66(6):1012-20. doi: 10.1016/j.eururo.2014.04.027. Epub 2014 May 22.

PMID:
24857538
4.

Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.

Haring A, Murtola TJ, Talala K, Taari K, Tammela TL, Auvinen A.

Scand J Urol. 2017 Feb;51(1):5-12. doi: 10.1080/21681805.2016.1271353. Epub 2017 Jan 13.

PMID:
28084175
5.

Metformin and the incidence of prostate cancer in patients with type 2 diabetes.

Azoulay L, Dell'Aniello S, Gagnon B, Pollak M, Suissa S.

Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):337-44. doi: 10.1158/1055-9965.EPI-10-0940. Epub 2010 Dec 10.

6.

Diabetes mellitus and the risk of prostate cancer.

Rosenberg DJ, Neugut AI, Ahsan H, Shea S.

Cancer Invest. 2002;20(2):157-65.

PMID:
11901534
7.

Cancer risks in thiazolidinedione users compared to other anti-diabetic agents.

Koro C, Barrett S, Qizilbash N.

Pharmacoepidemiol Drug Saf. 2007 May;16(5):485-92.

PMID:
17192841
8.

Antidiabetic medication and prostate cancer risk: a population-based case-control study.

Murtola TJ, Tammela TL, Lahtela J, Auvinen A.

Am J Epidemiol. 2008 Oct 15;168(8):925-31. doi: 10.1093/aje/kwn190. Epub 2008 Aug 11.

PMID:
18700234
9.

Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications.

Velicer CM, Dublin S, White E.

Prostate Cancer Prostatic Dis. 2007;10(1):46-51. Epub 2006 Oct 10.

PMID:
17033617
10.

Diabetes mellitus and prostate cancer risk among older men: population-based case-control study.

Coker AL, Sanderson M, Zheng W, Fadden MK.

Br J Cancer. 2004 Jun 1;90(11):2171-5.

11.
12.

Association between metformin use and risk of prostate cancer and its grade.

Margel D, Urbach D, Lipscombe LL, Bell CM, Kulkarni G, Austin PC, Fleshner N.

J Natl Cancer Inst. 2013 Aug 7;105(15):1123-31. doi: 10.1093/jnci/djt170. Epub 2013 Jul 13.

PMID:
23853056
13.

Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis.

Deng D, Yang Y, Tang X, Skrip L, Qiu J, Wang Y, Zhang F.

Diabetes Metab Res Rev. 2015 Sep;31(6):595-602. doi: 10.1002/dmrr.2645. Epub 2015 Apr 20.

PMID:
25708557
14.

An increase in the prevalence of type 1 and 2 diabetes in children and adolescents: results from prescription data from a UK general practice database.

Hsia Y, Neubert AC, Rani F, Viner RM, Hindmarsh PC, Wong IC.

Br J Clin Pharmacol. 2009 Feb;67(2):242-9. doi: 10.1111/j.1365-2125.2008.03347.x.

15.

Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case-control and 25 cohort studies.

Zhang F, Yang Y, Skrip L, Hu D, Wang Y, Wong C, Qiu J, Lei H.

Acta Diabetol. 2012 Dec;49 Suppl 1:S235-46. doi: 10.1007/s00592-012-0439-5. Epub 2012 Nov 4.

PMID:
23124624
16.

Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer.

García Rodríguez LA, González-Pérez A.

Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):649-53.

17.

Metformin does not alter the risk of lung cancer: a case-control analysis.

Bodmer M, Becker C, Jick SS, Meier CR.

Lung Cancer. 2012 Nov;78(2):133-7. doi: 10.1016/j.lungcan.2012.08.010. Epub 2012 Sep 7.

PMID:
22959242
18.

Diabetes mellitus and prostate cancer risk; a nationwide case-control study within PCBaSe Sweden.

Fall K, Garmo H, Gudbjörnsdottir S, Stattin P, Zethelius B.

Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1102-9. doi: 10.1158/1055-9965.EPI-12-1046. Epub 2013 Apr 11.

19.

Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.

Tseng CH.

Eur J Cancer. 2014 Nov;50(16):2831-7. doi: 10.1016/j.ejca.2014.08.007. Epub 2014 Sep 5.

PMID:
25201464
20.

Supplemental Content

Support Center